Microtest and Antisoma Form Manufacturing Pact

Agawam, MA (Mar. 26)-Contract manufacturer and testing laboratory Microtest (www.microtestlabs.com) signed a manufacturing deal with Antisoma (London, www.antisoma.com) to produce AS1411, a new drug being developed to treat various cancers.

Microtest will formulate and aseptically fill and finish AS1411 for Phase II clinical trials. Microtest also will perform stability testing on the product.

Microtest recently invested $7.5 million to expand its pharmaceutical testing services and fill-and-finish contract-manufacturing capabilities. The expansion included new pharmaceutical testing laboratories and new aseptic fill and finish manufacturing facilities.